CBDY Target Group Inc.

OTC Medicinal Chemicals & Botanical Products DE CIK: 0001586554
AI RATING
STRONG_SELL
95% Confidence

Investment Thesis

Target Group Inc. exhibits severe financial distress with negative stockholders' equity of -$7.4M, liabilities exceeding assets by $7.4M, and critical liquidity ratios (current ratio of 0.17x) indicating inability to meet short-term obligations. While revenue grew 77.2% YoY to $3.1M, the company is burning cash with negative operating cash flow of -$591.6K and continues to operate at significant losses despite strong 56.6% gross margins, suggesting structural operational problems.

Strengths

  • + Strong revenue growth of 77.2% year-over-year demonstrates market demand
  • + Healthy gross margin of 56.6% indicates viable product economics at production level
  • + Modest capital expenditure needs ($3.9K) suggest asset-light business model

Risks

  • ! Negative stockholders' equity of -$7.4M represents technical insolvency and bankruptcy risk
  • ! Critical liquidity crisis with current ratio of 0.17x and only $337.5K cash against $13.6M liabilities
  • ! Negative operating cash flow of -$591.6K combined with $7.5M long-term debt creates unsustainable burn rate
  • ! Operating losses of -$807.4K on $3.1M revenue indicate severe cost structure problems despite growth
  • ! No insider buying activity in past 90 days suggests lack of management confidence

Key Metrics to Watch

Financial Metrics

Revenue
3.1M
Net Income
-807.4K
EPS (Diluted)
$0.00
Free Cash Flow
-595.6K
Total Assets
6.2M
Cash
337.5K

Profitability Ratios

Gross Margin 56.6%
Operating Margin -25.7%
Net Margin -25.7%
ROE N/A
ROA -13.0%
FCF Margin -18.9%

Balance Sheet & Liquidity

Current Ratio
0.17x
Quick Ratio
0.06x
Debt/Equity
N/A
Debt/Assets
220.0%
Interest Coverage
-80,737.50x
Long-term Debt
7.5M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-03-21T23:42:11.535121 | Data as of: 2025-09-30 | Powered by Claude AI